129 related articles for article (PubMed ID: 3730608)
1. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B beta 54-118) in degradation products of fibrin and of fibrinogen.
Koppert PW; Koopman J; Haverkate F; Nieuwenhuizen W
Blood; 1986 Aug; 68(2):437-41. PubMed ID: 3730608
[TBL] [Abstract][Full Text] [Related]
2. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin.
Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
Mol Immunol; 1984 Jan; 21(1):89-94. PubMed ID: 6200769
[TBL] [Abstract][Full Text] [Related]
3. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A.
Koppert PW; Huijsmans CM; Nieuwenhuizen W
Blood; 1985 Sep; 66(3):503-7. PubMed ID: 4040783
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
[TBL] [Abstract][Full Text] [Related]
6. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a monoclonal antibody specific for fibrinogen and fibrin of human origin.
Sola B; Avner PR; Zilber MT; Connan F; Lévy D
Thromb Res; 1983 Mar; 29(6):643-53. PubMed ID: 6857603
[TBL] [Abstract][Full Text] [Related]
8. The sequence A alpha-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies.
Schielen WJ; Voskuilen M; Tesser GI; Nieuwenhuizen W
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8951-4. PubMed ID: 2813432
[TBL] [Abstract][Full Text] [Related]
9. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits.
Holvoet P; Stassen JM; Hashimoto Y; Spriggs D; Devos P; Collen D
Thromb Haemost; 1989 Apr; 61(2):307-13. PubMed ID: 2749602
[TBL] [Abstract][Full Text] [Related]
10. A neoantigenic determinant in the D-dimer fragment of fibrin.
Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
Dyr JE; Cajthamlová H; Suttnar J
Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
[TBL] [Abstract][Full Text] [Related]
12. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.
Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W
Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
[TBL] [Abstract][Full Text] [Related]
15. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
[TBL] [Abstract][Full Text] [Related]
16. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
[TBL] [Abstract][Full Text] [Related]
17. The sequence gamma-(312-324) is a fibrin-specific epitope.
Schielen WJ; Adams HP; van Leuven K; Voskuilen M; Tesser GI; Nieuwenhuizen W
Blood; 1991 May; 77(10):2169-73. PubMed ID: 1709373
[TBL] [Abstract][Full Text] [Related]
18. A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator.
Gargan PE; Ploplis VA; Scheu JD
Thromb Haemost; 1988 Jun; 59(3):426-31. PubMed ID: 3142080
[TBL] [Abstract][Full Text] [Related]
19. Novel monoclonal antibody that recognizes new neoantigenic determinant of D-dimer.
Doh HJ; Song KS; Kang MS; Kim DS; Kim KA; Kang J; Jang Y; Chung KH
Thromb Res; 2006; 118(3):353-60. PubMed ID: 16139872
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]